COVID-19: viral characterization, pathophysiology and prevention
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/7768 |
Resumo: | Introduction: There are seven known species of human coronavirus capable of causing respiratory diseases. The most recent is SARS-CoV-2, the etiologic agent of COVID-19. Objective: To evaluate the main characteristics of SARS-CoV-2, the pathophysiology of COVID-19 and the main measures for prevention and containment of disease progression. Methods: An integrative review was carried out between 2003 and 2020, based on: PubMed, Medline, SciELO, LILACS and Google Academic, using the descriptors: COVID-19, coronavirus, novel coronavirus, human, SARS virus, outbreak disease, viral pneumonia, all listed in MESH and DECS. Results: Of the 65 selected articles, 28 met the inclusion criteria. Conclusion: SARS-CoV-2 is an RNA virus whose protein S is involved in adsorption to the target cell membrane. It is transmitted through contact with contaminated surfaces, secretions or aerosols. In these, it remains viable for three hours, and up to three days on surfaces. Frequent hand washing, disinfecting surfaces, not sharing personal items, social distance of two meters and wearing facemasks when leaving home are recommended. Non-severe patients should be isolated at home for 14 days. Healthcare professionals should use PPE and be careful with potential sources of contamination, including urine and feces of patients during hygiene. |
id |
UNIFEI_4c6c9ecc52e52380acd90520c1632cf7 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/7768 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
COVID-19: viral characterization, pathophysiology and preventionCOVID-19: caracterización, fisiopatología y prevención viralCOVID-19: caracterização viral, fisiopatologia e prevençãoSARS-CoV-2Síndrome Respiratória Aguda GravePandemia.SARS-CoV-2Síndrome Respiratorio Agudo SeveroPandemia.SARS-CoV-2Severe Acute Respiratory SyndromePandemics.Introduction: There are seven known species of human coronavirus capable of causing respiratory diseases. The most recent is SARS-CoV-2, the etiologic agent of COVID-19. Objective: To evaluate the main characteristics of SARS-CoV-2, the pathophysiology of COVID-19 and the main measures for prevention and containment of disease progression. Methods: An integrative review was carried out between 2003 and 2020, based on: PubMed, Medline, SciELO, LILACS and Google Academic, using the descriptors: COVID-19, coronavirus, novel coronavirus, human, SARS virus, outbreak disease, viral pneumonia, all listed in MESH and DECS. Results: Of the 65 selected articles, 28 met the inclusion criteria. Conclusion: SARS-CoV-2 is an RNA virus whose protein S is involved in adsorption to the target cell membrane. It is transmitted through contact with contaminated surfaces, secretions or aerosols. In these, it remains viable for three hours, and up to three days on surfaces. Frequent hand washing, disinfecting surfaces, not sharing personal items, social distance of two meters and wearing facemasks when leaving home are recommended. Non-severe patients should be isolated at home for 14 days. Healthcare professionals should use PPE and be careful with potential sources of contamination, including urine and feces of patients during hygiene.Introducción: Hay siete especies conocidas de coronavirus humanos capaces de causar enfermedades respiratorias. El más reciente es el SARS-CoV-2, el agente etiológico de COVID-19. Objetivo: Evaluar las principales características del SARS-CoV-2, la fisiopatología del COVID-19 y las principales medidas para prevenir y contener la progresión de la enfermedad. Métodos: Se realizó una revisión integradora entre 2003 y 2020, basada en: PubMed, Medline, SciELO, LILACS y Google Academic, utilizando los descriptores: COVID-19, coronavirus, nuevo coronavirus, humano, virus SARS, brote de enfermedad, neumonía viral. , todos listados en MESH y DECS. Resultados: De los 65 artículos seleccionados, 28 cumplieron los criterios de inclusión. Conclusión: el SARS-CoV-2 es un virus de ARN cuya proteína S participa en la adsorción a la membrana celular diana. Se transmite por contacto con superficies, secreciones o aerosoles contaminados. En estos, permanece viable durante tres horas y hasta tres días en superficies. Se recomienda lavarse las manos con frecuencia, desinfectar superficies, no compartir objetos personales, distancia social de dos metros y usar máscaras al salir de casa. Los pacientes no graves deben aislarse en casa durante 14 días. Los profesionales de la salud deben usar EPP y tener cuidado con las posibles fuentes de contaminación, incluida la orina y las heces de los pacientes durante la higiene.Introdução: Há sete espécies conhecidas de coronavírus humanos capazes de causar doenças respiratórias. O mais recente é o SARS-CoV-2, o agente etiológico do COVID-19. Objetivo: Avaliar as principais características do SARS-CoV-2, a fisiopatologia do COVID-19 e as principais medidas de prevenção e contenção da progressão da doença. Métodos: Foi realizada uma revisão integrativa entre 2003 e 2020, com base em: PubMed, Medline, SciELO, LILACS e Google Academic, utilizando os descritores: COVID-19, coronavirus, novel coronavirus, human, SARS virus, outbreak disease, viral pneumonia, todos listados em MESH e DECS. Resultados: Dos 65 artigos selecionados, 28 atenderam aos critérios de inclusão. Conclusão: SARS-CoV-2 é um vírus de RNA cuja proteína S está envolvida na adsorção à membrana da célula alvo. É transmitido por contato com superfícies contaminadas, secreções ou aerossóis. Nestes, permanece viável por três horas e até três dias em superfícies. Recomenda-se lavagem frequente das mãos, desinfecção de superfícies, não compartilhamento de objetos pessoais, distância social de dois metros e uso de máscaras na saída de casa. Pacientes não graves devem ser isolados em casa por 14 dias. Os profissionais de saúde devem usar EPI e ter cuidado com as fontes potenciais de contaminação, incluindo urina e fezes de pacientes durante a higiene.Research, Society and Development2020-09-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/776810.33448/rsd-v9i9.7768Research, Society and Development; Vol. 9 No. 9; e750997768Research, Society and Development; Vol. 9 Núm. 9; e750997768Research, Society and Development; v. 9 n. 9; e7509977682525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/7768/6963Copyright (c) 2020 Sheila Chagas Mendes; Juliane Vismari de Oliveira; Ana Carolina Ferrari; Katharyna Cardoso de Gois; Lucas Duarte Nicolau; Marcelo Pires de Oliveira; Francisco Sandro Menezes-Rodrigues; Maria Lúcia Tomanik Packer; Fernando Luiz Affonso Fonseca; Flávia de Sousa Gehrkehttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMendes, Sheila Chagas Oliveira, Juliane Vismari de Ferrari, Ana Carolina Gois, Katharyna Cardoso de Nicolau, Lucas Duarte Oliveira, Marcelo Pires de Menezes-Rodrigues, Francisco Sandro Packer, Maria Lúcia Tomanik Fonseca, Fernando Luiz Affonso Gehrke, Flávia de Sousa 2020-09-18T01:42:11Zoai:ojs.pkp.sfu.ca:article/7768Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:30:23.711870Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
COVID-19: viral characterization, pathophysiology and prevention COVID-19: caracterización, fisiopatología y prevención viral COVID-19: caracterização viral, fisiopatologia e prevenção |
title |
COVID-19: viral characterization, pathophysiology and prevention |
spellingShingle |
COVID-19: viral characterization, pathophysiology and prevention Mendes, Sheila Chagas SARS-CoV-2 Síndrome Respiratória Aguda Grave Pandemia. SARS-CoV-2 Síndrome Respiratorio Agudo Severo Pandemia. SARS-CoV-2 Severe Acute Respiratory Syndrome Pandemics. |
title_short |
COVID-19: viral characterization, pathophysiology and prevention |
title_full |
COVID-19: viral characterization, pathophysiology and prevention |
title_fullStr |
COVID-19: viral characterization, pathophysiology and prevention |
title_full_unstemmed |
COVID-19: viral characterization, pathophysiology and prevention |
title_sort |
COVID-19: viral characterization, pathophysiology and prevention |
author |
Mendes, Sheila Chagas |
author_facet |
Mendes, Sheila Chagas Oliveira, Juliane Vismari de Ferrari, Ana Carolina Gois, Katharyna Cardoso de Nicolau, Lucas Duarte Oliveira, Marcelo Pires de Menezes-Rodrigues, Francisco Sandro Packer, Maria Lúcia Tomanik Fonseca, Fernando Luiz Affonso Gehrke, Flávia de Sousa |
author_role |
author |
author2 |
Oliveira, Juliane Vismari de Ferrari, Ana Carolina Gois, Katharyna Cardoso de Nicolau, Lucas Duarte Oliveira, Marcelo Pires de Menezes-Rodrigues, Francisco Sandro Packer, Maria Lúcia Tomanik Fonseca, Fernando Luiz Affonso Gehrke, Flávia de Sousa |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Mendes, Sheila Chagas Oliveira, Juliane Vismari de Ferrari, Ana Carolina Gois, Katharyna Cardoso de Nicolau, Lucas Duarte Oliveira, Marcelo Pires de Menezes-Rodrigues, Francisco Sandro Packer, Maria Lúcia Tomanik Fonseca, Fernando Luiz Affonso Gehrke, Flávia de Sousa |
dc.subject.por.fl_str_mv |
SARS-CoV-2 Síndrome Respiratória Aguda Grave Pandemia. SARS-CoV-2 Síndrome Respiratorio Agudo Severo Pandemia. SARS-CoV-2 Severe Acute Respiratory Syndrome Pandemics. |
topic |
SARS-CoV-2 Síndrome Respiratória Aguda Grave Pandemia. SARS-CoV-2 Síndrome Respiratorio Agudo Severo Pandemia. SARS-CoV-2 Severe Acute Respiratory Syndrome Pandemics. |
description |
Introduction: There are seven known species of human coronavirus capable of causing respiratory diseases. The most recent is SARS-CoV-2, the etiologic agent of COVID-19. Objective: To evaluate the main characteristics of SARS-CoV-2, the pathophysiology of COVID-19 and the main measures for prevention and containment of disease progression. Methods: An integrative review was carried out between 2003 and 2020, based on: PubMed, Medline, SciELO, LILACS and Google Academic, using the descriptors: COVID-19, coronavirus, novel coronavirus, human, SARS virus, outbreak disease, viral pneumonia, all listed in MESH and DECS. Results: Of the 65 selected articles, 28 met the inclusion criteria. Conclusion: SARS-CoV-2 is an RNA virus whose protein S is involved in adsorption to the target cell membrane. It is transmitted through contact with contaminated surfaces, secretions or aerosols. In these, it remains viable for three hours, and up to three days on surfaces. Frequent hand washing, disinfecting surfaces, not sharing personal items, social distance of two meters and wearing facemasks when leaving home are recommended. Non-severe patients should be isolated at home for 14 days. Healthcare professionals should use PPE and be careful with potential sources of contamination, including urine and feces of patients during hygiene. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/7768 10.33448/rsd-v9i9.7768 |
url |
https://rsdjournal.org/index.php/rsd/article/view/7768 |
identifier_str_mv |
10.33448/rsd-v9i9.7768 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/7768/6963 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 9; e750997768 Research, Society and Development; Vol. 9 Núm. 9; e750997768 Research, Society and Development; v. 9 n. 9; e750997768 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052803691053056 |